comprehensive -WSS

comprehensive

author：knowledge 2025-09-29 23:12:16 - browse：392

Doctor sitting at a crowded desk. -- first opinion coverage from STAT — Adobe

SAN FRANCISCO — If you learned anything about nonprofit hospitals on the first day of the J.P. Morgan Healthcare Conference, it’s that they’ve all but abandoned the prospect of making significant profit on patient care. Instead, they’re fully throwing their weight into other ways of making money — things like developing drugs or selling insurance.

Making money outside of patient care — or “revenue diversification,” if you prefer industry jargon — has always made appearances on hospital slides at the annual investor conference in San Francisco. This year, though, hospital executives are projecting a sense of urgency around growing profit in other areas to make up for losing money on their bread and butter: taking care of patients in hospitals.

“It used to be nice to have, but now it’s a must-have, especially for not-for-profit health systems,” Niyum Gandhi, the chief financial officer of Boston’s Mass General Brigham said in an interview with STAT after his presentation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： CDC wastewater surveillance dashboard to track bird flu hotspots

WSS

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

What nurses really want: sufficient staffing for patient care

What drug price negotiations mean for Medicare Part D

Humana sues Biden admin over Medicare Advantage audit rule

The 10 drugs up first for Medicare price negotiation

Shionogi licenses Pompe disease therapy from Maze Therapeutics

focus

comprehensive

Wikipedia

Psychedelics group wrestles with new pharma identity

AstraZeneca chief proposes a novel edit to the drug pricing bill

Sports medicine is finally prioritizing gender equality

Crinetics acromegaly drug succeeds in late

Walensky prepares to leave CDC — and Congress — behind

Illumina names Agilent executive as new CEO

At least 13 dead in Texas as scorching temps continue

A rare thyroid diagnosis led to unexpected, all

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Trump surgeon general acknowledges mistakes during Covid

focus

Illumina names Agilent executive as new CEO

NIH nominee Bertagnolli will get October confirmation hearing

After gene therapy, two congenitally deaf children hear for the first time

What nurses really want: sufficient staffing for patient care

How to protect patients from sexual assault

First recipient of genetically engineered pig kidney has died

entertainment

focus

focus

hotspot